(Q43292535)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19678795%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

editorial

0 references

title

Metformin: diamonds are forever (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19678795%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19678795%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

N Papanas

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19678795%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

D P Mikhailidis

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19678795%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

language of work or name

English

0 references

publication date

1 October 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19678795%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Pharmacotherapy

5 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19678795%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19678795%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19678795%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

2395-2397

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19678795%20AND%20SRC:MED&resulttype=core&format=json

Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes

5 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656560903176453

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903176453

10-year follow-up of intensive glucose control in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903176453

Cardiovascular outcomes in trials of oral diabetes medications: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903176453

The effect of metformin on blood pressure, plasma cholesterol and triglycerides in type 2 diabetes mellitus: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903176453

Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903176453

Gastrointestinal tolerability of extended-release metformin tablets compared to immediate-release metformin tablets: results of a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903176453

Adherence in patients transferred from immediate release metformin to a sustained release formulation: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903176453

Metformin's contraindications: needed for now.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903176453

Metformin and lactic acidosis in patients with type 2 diabetes--from pride and prejudice to sense and sensibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903176453

Contraindications can damage your health--is metformin a case in point?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903176453

Long-term effects of metformin on metabolism and microvascular and macrovascular disease in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903176453

Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903176453

Preventing type 2 diabetes in high risk patients: an overview of lifestyle and pharmacological measures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560903176453

Metformin monotherapy for type 2 diabetes mellitus

21 January 2018

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD002966.PUB3

Identifiers

DOI

10.1517/14656560903176453

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19678795%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference